Search Results for "days"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for days. Results 441 to 450 of 1865 total matches.

In Brief: One Drop or Two

   
The Medical Letter on Drugs and Therapeutics • Jun 19, 2006  (Issue 1237)
patch 9 hours a day for 1 week and then crossed over to the other treatment. 2 The primary endpoint ...
Many prescriptions for eye drops call for instillation of 1-2 drops. But Medical Letter consultants in ophthalmology seem to agree that all eye drops should generally be given in doses of only one drop. The volume of a single drop can vary with the viscosity of the solution, the design of the dropper, and patient technique. The average volume of a drop is 35-50 microliters, but can be as high as 75 microliters. An eye brimming with fluid holds 30 microliters at best, so even one drop is often an overdose. A second either washes out the first or increases the possibility of systemic toxicity,...
Med Lett Drugs Ther. 2006 Jun 19;48(1237):49 |  Show IntroductionHide Introduction

Drugs for Hypothyroidism

   
The Medical Letter on Drugs and Therapeutics • Feb 20, 2023  (Issue 1670)
, 70-80% of an oral dose of LT4 is absorbed from the GI tract. LT4 has a half-life of about 7 days ...
Primary hypothyroidism is usually the result of Hashimoto's (autoimmune) thyroiditis, thyroidectomy, or radioactive iodine therapy. Treatment of hypothyroidism with replacement doses of thyroid hormone is usually lifelong. Levothyroxine (LT4; synthetic thyroxine; Synthroid, and others) is the drug of choice.1
Med Lett Drugs Ther. 2023 Feb 20;65(1670):25-9   doi:10.58347/tml.2023.1670a |  Show IntroductionHide Introduction

Correction: Drugs for Helicobacter pylori Infection

   
The Medical Letter on Drugs and Therapeutics • Sep 11, 2017  (Issue 1529)
on page 116, the price provided for Prevpac was for a 14-day supply, rather than for a 10-day supply ...
In Table 3 on page 116 (Med Lett Drugs Ther 2017; 59:113), the price provided for Prevpac was for a 14-day supply, rather than for a 10-day supply as stated in footnote 1. The footnote has been corrected and the price of the generic formulation of Prevpac has been added.
Med Lett Drugs Ther. 2017 Sep 11;59(1529):154 |  Show IntroductionHide Introduction

Idarubicin

   
The Medical Letter on Drugs and Therapeutics • Sep 06, 1991  (Issue 852)
with idarubicin, according to the manufacturer, was 87 days, while with daunorubicin it was 169 days. ADVERSE ...
Idarubicin hydrochloride (Idamycin - Adria), an anthracycline structurally related to daunorubicin (Cerubidine, and others) and doxorubicin (Adriamycin, and others), was recently approved in the USA for treatment of acute myelogenous leukemia (AML) in adults.
Med Lett Drugs Ther. 1991 Sep 6;33(852):84-5 |  Show IntroductionHide Introduction

Regorafenib (Stivarga) for Metastatic Colorectal Cancer and GIST (online only)

   
The Medical Letter on Drugs and Therapeutics • Apr 29, 2013  (Issue 1415)
— The dosage of regorafenib is 160 mg (4 tablets) daily with a low-fat breakfast for the first 21 days of a 28 ...
Regorafenib (Stivarga – Bayer), a multikinase inhibitor, has been approved by the FDA for treatment of patients with metastatic colorectal cancer previously treated with multiple other regimens specified in the labeling. It has also been approved for use in treatment-refractory, locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST).
Med Lett Drugs Ther. 2013 Apr 29;55(1415):36 |  Show IntroductionHide Introduction

Low-Dose Aspirin for Prevention of Preeclampsia

   
The Medical Letter on Drugs and Therapeutics • Jun 23, 2014  (Issue 1445)
-150 mg/day) started as early as the second trimester was associated with absolute risk reductions ...
The American College of Obstetricians and Gynecologists (ACOG) and the US Preventive Services Task Force (USPSTF) have recommended that women at risk for preeclampsia take low-dose aspirin daily after the first trimester.
Med Lett Drugs Ther. 2014 Jun 23;56(1445):49 |  Show IntroductionHide Introduction

In Brief: A Shorter Treatment Regimen for Tuberculosis (online only)

   
The Medical Letter on Drugs and Therapeutics • Aug 23, 2021  (Issue 1631)
Ethambutol 800-1600 mg3 + once/day x 18 wks Pyrazinamide 1000-2000 mg4 once/day x 8 wks Rifapentine ...
In a clinical trial conducted by the CDC's Tuberculosis Trials Consortium in collaboration with the NIH-funded AIDS Clinical Trials Group, a new 4-month regimen for treatment of drug-susceptible pulmonary tuberculosis was found to be noninferior to 6 months of standard treatment.
Med Lett Drugs Ther. 2021 Aug 23;63(1631):e3 |  Show IntroductionHide Introduction

Table: GLP-1 and GIP/GLP-1 Receptor Agonists for Chronic Weight Management (online only)

   
The Medical Letter on Drugs and Therapeutics • Aug 05, 2024  (Issue 1708)
weight-related comorbidity ▪ Children 12-17 years old who weigh >60 kg with obesity 3 mg SC once/day ...
View the Table: GLP-1 and GIP/GLP-1 Receptor Agonists for Chronic Weight Management
Med Lett Drugs Ther. 2024 Aug 5;66(1708):e1-2   doi:10.58347/tml.2024.1708d |  Show IntroductionHide Introduction

Antiplatelet Therapy for Patients with Stents

   
The Medical Letter on Drugs and Therapeutics • Aug 11, 2008  (Issue 1292)
) at 30 days among patients preloaded with 300 mg of clopidogrel, even though 25% of the placebo group ...
The antiplatelet agents aspirin and clopidogrel (Plavix, and others) are used in most patients undergoing percutaneous coronary intervention (PCI) to prevent stent thrombosis and to reduce the occurrence of peri-, post-procedural and late cardiovascular events. Despite a large number of randomized trials of these agents in such patients, the optimal dosage and duration of treatment with these drugs, and whether other drugs should be added, is unclear.
Med Lett Drugs Ther. 2008 Aug 11;50(1292):61-3 |  Show IntroductionHide Introduction

Saxagliptin (Onglyza) for Type 2 Diabetes

   
The Medical Letter on Drugs and Therapeutics • Nov 02, 2009  (Issue 1324)
and exercise (HbA1c 7-10%) found that saxagliptin 2.5 mg/day reduced HbA1c by 0.43% from baseline, 5 mg/day ...
Saxagliptin (Onglyza - Bristol-Myers Squibb), the second oral dipeptidyl peptidase-4 (DPP-4) inhibitor to be marketed in the US, has been approved by the FDA for treatment of adults with type 2 diabetes.
Med Lett Drugs Ther. 2009 Nov 2;51(1324):85-6 |  Show IntroductionHide Introduction